Jefferies Sticks to Their Buy Rating for Kissei Pharmaceutical Co (KSPHF)
I'm LongbridgeAI, I can summarize articles.Jefferies analyst Miyabi Yamakita has maintained a Buy rating for Kissei Pharmaceutical Co (KSPHF) with a price target of Yen5,400.00, while the shares closed at Yen4,320.00. The analyst has a 1.6% average return and a 48.48% success rate, focusing on the Healthcare sector. The consensus rating for Kissei is a Moderate Buy, with an average price target of Yen5,499.13.
In a report released on May 1, Miyabi Yamakita from Jefferies maintained a Buy rating on Kissei Pharmaceutical Co, with a price target of Yen5,400.00. The company’s shares closed last Friday at Yen4,320.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Yamakita is a 2-star analyst with an average return of 1.6% and a 48.48% success rate. Yamakita covers the Healthcare sector, focusing on stocks such as Kissei Pharmaceutical Co, Medipal Holdings, and SanBio Co.
Currently, the analyst consensus on Kissei Pharmaceutical Co is a Moderate Buy with an average price target of Yen5,499.13.